CD38 splice variants and uses thereof
The invention provides for a substantially purified polypeptide referred to herein as CD38JL that is a CD38 splice variant comprised of the polypeptide of SEQ ID NO: 1 or a fragment thereof. The invention also provides methods for treating preventing and diagnosing disorders associated with expression of CD38JL.
Boehringer Ingelheim Pharmaceutical, Inc.
A A A A C A A
A61P A61P A61K A61P C07K A61P A61P
inventional inventional additional inventional inventional inventional inventional
Zhenhao Baerbel Jun Xiang
Qi LoSacco Li Li